What is the Difference Between Relapsing and Progressive MS?

Click here to receive MS news via e-mail
news_11_Artboard 343 copy 108

Recently, the U.S. Food and Drug Administration (FDA) gave priority review to a request to approve Ocrevus (ocrelizumab) as a treatment for both relapsing and primary progressive MS.

But each form of the disease has its own peculiarities.

In this interview from MSWorld at ACTRIMS Forum 2016, Dr. John Schafer, Director of the Mercy MS Center in Sacramento, California, talks to Dr. Daniel Kantor about the differences between relapsing and progressive multiple sclerosis (MS).

Learn more about the 1st potential therapy for primary progressive MS, Ocrelizumab here.

Multiple Sclerosis News Today is strictly a news and information website about the disease. It does not provide medical advice, diagnosis or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.

Click here to receive MS news via e-mail

One comment

Leave a Comment

Your email address will not be published. Required fields are marked *